Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 8
Submit an article Journal homepage
495
Views
3
CrossRef citations to date
0
Altmetric
RESPIRATORY: Original Article

Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy

Vamsi BolluSunovion Pharmaceuticals, Inc. Marlborough, MAUSACorrespondence[email protected]
,
Flavia EjzykowiczUniversity of Southern California Los Angeles, CAUSA
,
Krithika RajagopalanSunovion Pharmaceuticals, Inc. Marlborough, MAUSA
,
John KarafilidisSunovion Pharmaceuticals, Inc. Marlborough, MAUSA
&
Joel W. HayUniversity of Southern California Los Angeles, CAUSA
Pages 1082-1088 | Accepted 12 Jun 2013, Published online: 26 Jun 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Brian W. Carlin, Sandra K. Schuldheisz, Imre Noth & Gerard J. Criner. (2017) Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgraduate Medicine 129:7, pages 725-733.
Read now
Yaozhu J. Chen, Charles Makin, Vamsi K. Bollu, Maryam Navaie & Bartolome R. Celli. (2016) Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting 2-agonists. Journal of Medical Economics 19:1, pages 11-20.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.